AstraZeneca's CEO Pascal Soriot warns the company must innovate at 'Chinese speed' to compete with emerging pharmaceutical rivals, citing the automotive industry's loss to Chinese electric vehicle dominance. Despite confidence in hitting $80bn 2030 sales targets, Soriot acknowledges the threat from Chinese innovators in novel drug technologies.
Infighting between France's Socialist Party (PS) and further-left La France Insoumise (LFI) over a halal chicken shop, Master Poulet, in Saint-Ouen-sur-Seine, near Paris, raises concerns about unity against the far-right ahead of presidential elections.
President Trump plans to impose a 100% tariff on imported generic drugs from August 2028, rising to 200% after a year, aiming to reshore U.S. pharmaceutical production, with experts warning of potential price increases and shortages.
Indigenous leaders on the Brazil-Peru border report their communities are "taken hostage" by organised crime groups involved in drug trafficking, illegal logging, and mining. The Asháninka people, facing severe threats, appealed to the Brazilian government for permanent security presence and protection, warning of disastrous self-defense if the state fails to act.
Australia's Therapeutic Goods Administration (TGA) has warned about a "rare but severe" eye disorder, non-arteritic anterior ischaemic optic neuropathy (NAION), linked to type 2 diabetes and obesity treatments like Ozempic and Mounjaro. The warning, based on 36 reported cases, advises patients to seek urgent medical attention for sudden vision loss but not to stop treatment without consulting a doctor.
A news briefing highlights the Christian Brothers' agreement to compensate abuse survivors, new US trade tariffs on Australian exports, and domestic concerns over an impending El Niño summer, alongside other headlines including a Socceroos star's alleged drug test and airport advertising disputes.
Australia's TGA has issued a safety warning for GLP-1 drugs like Ozempic, Mounjaro, and Wegovy, linking them to non-arteritic anterior ischaemic optic neuropathy (NAION), a rare eye disorder causing potential permanent vision loss. Experts advise caution but not panic, stressing consultation with prescribers.
U.S. President Donald Trump's proposed tariffs on generic drugs will raise medicine prices for American patients, according to Dr. Reddy's Laboratories CEO Erez Israeli. Indian drugmakers, who supply nearly half of U.S. generics, cannot absorb 100-200% tariffs due to thin margins, and relocating operations to the U.S. is deemed unfeasible and too lengthy.
Astronauts on long Mars missions face medicine expiration. A UC San Diego study proposes growing pharmaceuticals mid-flight, cultivating cowpea mosaic virus (CPMV) on plants in simulated microgravity. This method could provide fresh medicine, addressing issues like blood clots and routine ailments experienced on the ISS.
Galderma CEO Flemming Ørnskov stated that the increased use of weight-loss drugs like Ozempic and Wegovy presents a "significant opportunity" for the aesthetics company, particularly in mitigating facial sagging. The company reported nearly 25% sales growth, with U.S. growth outpacing other regions at 32%.
Jordan Kenyon, 30, high on GHB and on parole, caused a fatal crash in Stonehaven, Geelong, killing 12-year-old Mia Rossiter and seriously injuring her family. A Victorian judge likened his actions to "Russian roulette," noting Kenyon's extensive dangerous driving record. Kenyon pleaded guilty and awaits sentencing.
US President Trump announced 100-200% tariffs on generic medicines from Aug 2028 unless manufacturing relocates to the US. This poses a significant challenge for India's $30B pharma industry, which supplies 47% of US generic prescriptions, potentially making exports unviable and raising US drug prices.
President Trump proposed tariffs up to 200% on imported generic medicines after a two-year grace period, aiming to boost U.S. production. The generic drug industry, operating on thin margins, warns that shifting manufacturing domestically within the timeframe is challenging and could lead to market exits or price increases, impacting patient access to affordable medicines.
US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could pressure Indian pharmaceutical exporters, but India's cost advantage may help many drugs remain competitive in the US market, according to the Global Trade Research Initiative (GTRI).
President Trump announced a new tariff schedule for generic drugs, starting with two years of zero tariffs, then a 100% levy in August 2028, rising to 200% in 2029. This policy aims to incentivize generic drugmakers to move production to the U.S., significantly impacting countries like India, which supplies nearly 50% of U.S. generic medicines.
President Trump plans 100-200% tariffs on generic drugs by 2028 to reshore production, impacting Indian pharma. US and China are set for AI talks amid IP theft concerns. US strikes Iran for an 11th night as Secretary Rubio questions Iran's seriousness in peace talks. Alphabet and Tesla earnings are also due.
Staff at Penal Colony No. 17 in Nizhny Novgorod, Russia, intercepted a cat attempting to smuggle banned substances in two fabric collars for inmates. The Federal Penitentiary Service (FSIN) confirmed the cat was caught, its collars removed, and the narcotics verified by a sniffer dog before the animal was released unharmed.
Shane Brendan Wesley appeared in Kalgoorlie Magistrates Court for allegedly stabbing a woman multiple times on Hannan Street while dealing drugs. The woman is stable, and Wesley faces attempted murder and drug charges, remanded until August.
China's NMPA has approved a rare-disease therapy for commercial sales to treat narcolepsy type 1 in individuals aged 16 and older. The unnamed drug previously received fast-track status in the US and orphan-drug designation in Japan and the EU, indicating international recognition for its importance.
Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.
Novo Nordisk has filed a lawsuit in the US against Eli Lilly, accusing its rival of false advertising regarding the superiority of its weight-loss drugs, Mounjaro and Zepbound. Novo Nordisk claims Eli Lilly compared lower doses of Novo Nordisk's drugs with higher doses of its own, omitting newer options.
Hong Kong police arrested 78 people, including a 16-year-old, in an anti-triad operation targeting illegal gambling at Happy Valley Racecourse. The crackdown, conducted from July 7 to Monday, uncovered a syndicate involved in illicit horse racing betting.
Cannondale-EF team boss Jonathan Vaughters defended pre-dawn doping tests at the Tour de France, stating they could have exposed cycling's blood-doping era decades earlier. His comments follow complaints from riders like Tadej Pogačar and Jonas Vingegaard about disrupted sleep due to the unannounced checks.
Two US biotech companies, Akston Biosciences and OKAVA Pharmaceuticals, are testing experimental GLP-1 weight-loss treatments for overweight cats, aiming to bring the blockbuster drug class into pet medicine amidst a growing pet obesity problem and increasing owner spending on pet health.
